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Structural insights on TRPV5 gating by endogenous
modulators
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TRPV5 is a transient receptor potential channel involved in calcium reabsorption. Here we
investigate the interaction of two endogenous modulators with TRPV5. Both phosphatidyli-
nositol 4,5-bisphosphate (PI(4,5)P2) and calmodulin (CaM) have been shown to directly bind
to TRPV5 and activate or inactivate the channel, respectively. Using cryo-electron micro-
scopy (cryo-EM), we determined TRPV5 structures in the presence of dioctanoyl PI(4,5)P2
and CaM. The PI(4,5)P2 structure reveals a binding site between the N-linker, S4-S5 linker
and S6 helix of TRPV5. These interactions with PI(4,5)P2 induce conformational rearrange-
ments in the lower gate, opening the channel. The CaM structure reveals two TRPV5
C-terminal peptides anchoring a single CaM molecule and that calcium inhibition is mediated
through a cation-π interaction between Lys116 on the C-lobe of calcium-activated CaM and
Trp583 at the intracellular gate of TRPV5. Overall, this investigation provides insight into the
endogenous modulation of TRPV5, which has the potential to guide drug discovery.
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The calcium ion is vital for an array of cellular functions,and in the human body the kidneys regulate calciumhomeostasis by filtration and reabsorption1. Around 99%
of calcium is reabsorbed by the kidney tubules1, with ~15% of
that reabsorption occurring via transient receptor potential
vanilloid 5 (TRPV5) channels in the distal convoluted tubule and
collecting tubule. TRPV5 is specialized for this task and is only
expressed in the apical membrane of kidney epithelial cells in the
distal convoluted tubule and collecting tubule2,3. When open,
TRPV5 allows calcium in the urine to flow along a concentration
gradient through the channel pore into the cell. This gradient is
maintained by the calcium sequestering protein calbindin, which
delivers calcium to active transport proteins at the basolateral
membrane of the epithelium, which then export the ions into the
blood stream2,3. Though this mechanism of calcium reabsorption
is responsible for only ~15% of total calcium reabsorbed in the
kidney, TRPV5 activity is critical for the homeostatic balance of
calcium2,3. This is exemplified by TRPV5 knock out mice, which
have been reported to have systemic calcium imbalance in the
form of hypercalciuria and bone mineral loss2,3. In humans,
single-nucleotide polymorphisms in TRPV5 in African–
American populations result in a significant increase in calcium
reabsorption that is correlated with a lower risk of
nephrolithiasis2,3. Together, these observations suggest that
TRPV5 could be a potential drug target for human disorders
involving altered calcium homeostasis.
TRPV5 is a calcium selective channel that displays constitutive
activity in the presence of basal levels of the membrane phos-
pholipid phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2)2.
The TRPV5 channel is tetrameric and consists of classic
TRPV family features, including six transmembrane helices
(S1–S6), N-terminal ankyrin repeats (ARD), and the TRP
domain4 (Fig. 1a). TRPV6 is a closely related epithelial Ca2+
channel that shows a high level of sequence homology
with TRPV53; these two channels have a much lower level of
sequence homology with other members of the TRPV subfamily.
The regulation and biophysical properties of TRPV5 and TRPV6
are similar, and they are functionally quite different from the
rest of the TRPV subfamily3. PI(4,5)P2 is found in the
inner leaflet of the plasma membrane and it has been shown to
be essential for the activity of both TRPV55,6 and TRPV67.
For TRPV6, the activating effect of PI(4,5)P2 was demonstrated
in planar lipid bilayers, providing definitive evidence for direct
effect on the channel8. However, the molecular details of the
PI(4,5)P2 interaction with TRPV5 and TRPV6 are essentially
unknown.
To prevent excess flow of calcium ions into the cell, both
TRPV5 and TRPV6 have been shown to rapidly inactivate
through a calcium-dependent mechanism9. Calmodulin
(CaM), a calcium sensing protein, has been shown to be
involved in this inactivation by directly interacting with the
last 30 amino acids of the TRPV5 C-terminus10. While the
role of the distal C-terminal binding site is well established in
CaM-mediated inactivation of TRPV510 and the closely rela-
ted TRPV611–13, the binding stoichiometry and the con-
formational changes that take place as a consequence of the
binding of CaM to the channel have been unclear3. The
absence of this information prevents us from further under-
standing TRPV5 function and regulation in the kidney.
In this study, we used cryo-electron microscopy (cryo-EM) to
uncover the molecular mechanisms of TRPV5 gating via endo-
genous modulators. Investigating TRPV5 modulation with cryo-
EM permitted us to gain insight regarding TRPV5 gating and
potentially form the basis for rational drug design for the treat-
ment and prevention of hypercalciuria and nephrolithiasis in
future studies.
Results
Structures of lipid-bound and PI(4,5)P2-bound TRPV5.
TRPV5 is part of the tightly regulated system of calcium home-
ostasis in the human body2. Two endogenous mechanisms of
regulation, binding of PI(4,5)P2 or CaM to TRPV5, result in
activation or inactivation of the channel13, respectively. To
understand these mechanisms of modulation, first we used cryo-
EM to determine the structure of detergent solubilized full-length
rabbit TRPV5 in the presence of the 200 μM dioctanoyl (diC8) PI
(4,5)P2, a soluble form of PI(4,5)P2. This concentration is ~three
times the EC50 of diC8 PI(4,5)P2 for TRPV6, and TRPV5 has a
slightly higher apparent affinity for diC8 PI(4,5)P214, thus this
concentration was expected to result in near saturation of TRPV5
with diC8 PI(4,5)P2. During the cryo-EM structure determination
process, one stable class emerged and was refined to an overall
resolution of 3.9 Å (Fig. 1b, Supplementary Figure 1, Supple-
mentary Figure 2, Supplementary Table 1). The vast majority of
this TRPV5 cryo-EM map is at high resolution (3–3.5 Å) as side
chains are clearly visible in the transmembrane region of the
channel (Supplementary Figure 1, Supplementary Figure 3). This
allowed for accurate model building in both the transmembrane
domain (TMD) and the ankyrin repeat domain (ARD) (Fig. 1c,
Supplementary Figure 3). Highly flexible areas such as the very
distal C-terminal and N-terminal were unable to be resolved.
Interestingly, five non-protein densities per monomer were
identified in this cryo-EM map (Fig. 1b). None of these could be
identified as diC8 PI(4,5)P2, and were attributed to annular lipids
that had high enough affinity for TRPV5 to be co-purified with
the protein. Similarly shaped non-protein densities were also
assigned as lipids in a recently reported human TRPV6 cryo-EM
structure15. Therefore, we will refer to this channel reconstruction
as lipid-bound TRPV5.
The lipid-bound TRPV5 pore contains three residues that are
involved in pore constriction: Asp542, Ile575, and Trp583
(Fig. 1d). Unlike the previously published structure of TRPV54,
there is clear density in the lipid-bound TRPV5 map indicating
that the four Asp542 that constitute the highly specific Ca2+
selectivity filter are pointing directly into the pore in a similar
fashion to the rat TRPV6 crystal structures16,17. The lipid-bound
TRPV5 lower gate appears to consist of Ile575 and Trp583
(Fig. 1d, e). These residues do not constrict the pore to the point
of blocking ion translocation, indicating that the lower gate is
open (Fig. 1e), as seen in the human TRPV6 cryo-EM structure15.
This suggests that the pore of the lipid-bound TRPV5 structure
may be in a closed pre-open conformation.
Based on these findings, we decided to increase diC8 PI(4,5)P2
concentration to 400 μM and use nanodiscs to capture TRPV5 in
the PI(4,5)P2-bound state. During the cryo-EM structure determi-
nation process we noted that even before masking and 3D
classification in RELION18,19 the initial 3D reconstruction
contained a non-protein density that resembled diC8 PI(4,5)P2 in
both size and shape (Fig. 2a, Supplementary Figure 4). Next, we
used particle subtraction and 3D classification that was focused on
the diC8 PI(4,5)P2-binding site using a mask which included the
entire TRP domain helix, the base of the S6 helix, and the head
group of the diC8 PI(4,5)P2 (Supplementary Figure 4). This
classification yielded three classes with good features: one without
diC8 PI(4,5)P2 and two with diC8 PI(4,5)P2 (Supplementary
Figure 4). The class without diC8 PI(4,5)P2 yielded a TRPV5 struc-
ture at 4.4 Å, which clearly resembled the lipid-bound TRPV5 in
detergent (Supplementary Figure 5). Due to high similarity between
the detergent and nanodisc lipid-bound TRPV5 structures (Sup-
plementary Figure 5), we will only describe the lipid-bound TRPV5
in detergent as it was determined at a higher resolution
(Supplementary Figure 1, Supplementary Figure 3, Supplementary
Figure 5). The two classes with diC8 PI(4,5)P2 density, after
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additional classification and refinement, produced a single
TRPV5 structure in a diC8 PI(4,5)P2-bound state at 4.0 Å (Fig. 2b,
Supplementary Figure 6, Supplementary Figure 7, Supplementary
Table 1). All structures identified in nanodiscs revealed non-protein
densities in similar positions to those attributed to annular lipids in
the lipid-bound TRPV5 structure in detergent (Fig. 1b, Fig. 2a, b,
Supplementary Figure 5).
The PI(4,5)P2-binding site in the TRPV5 channel is located
between the N-linker (Arg302, Arg305), S4-S5 linker (Lys484),
and the S6 helix (Arg584) of the channel (Fig. 2c). These results
show an excellent correlation with predictions by earlier
molecular dynamics (MD) simulations performed on the
homologous TRPV6 channel (Fig. 2d, Supplementary Figure 8).
These simulations predicted that residues Arg302, Arg305, and
Lys484 are involved in the TRPV6 interaction with PI(4,5)P2
(Fig. 2d, Supplementary Figure 8). Moreover, when these
predicted PI(4,5)P2-interacting TRPV6 residues (Arg302,
Arg305, Lys484) were mutated to glutamine, the channel had
increased sensitivity to depletion of PI(4,5)P2 with high
concentrations of wortmannin, which inhibits PI4-kinases
(Fig. 2e, Supplementary Figure 9). This result indicates reduced
apparent affinity for PI(4,5)P2, which is expected if a PI(4,5)P2-
interacting residue is mutated20. The current amplitudes of the
Arg302Gln and Lys484Gln mutants were also significantly lower
than wild type TRPV6 (Supplementary Figure 9), which is
consistent with decreased apparent affinity of the channel for PI
(4,5)P2. The Arg305 residue showed a less clear contact with PI
(4,5)P2 compared to Arg302 and Lys484, interacting with only
three out of four subunits in MD simulations (Supplementary
Figure 8). Accordingly, this mutant showed a less pronounced
trend to be inhibited more by wortmannin and had a smaller
amplitude, but these effects did not reach statistical significance
from wild type (Fig. 2e, Supplementary Figure 9). When we
mutated residues Arg302 and Lys484 to glutamine in TRPV5 and
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Fig. 1 Lipid-bound TRPV5 structure in detergent. a A schematic representation of the TRPV5 domains per channel monomer. Dashed lines indicate regions
for which a model could not be built. b Density map of lipid-bound TRPV5 at 3.9 Å resolution. Density for TRPV5 is shown in gray and the densities
attributed to annular lipids are shown in khaki. c Cartoon representation of the lipid-bound TRPV5 model. The TRPV5 tetramer is depicted as pink cartoons
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and lower gate. e Plot of pore radii of lipid-bound TRPV5 as a function of distance through the pore. The dotted line indicates the radius of a dehydrated
calcium ion
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performed analogous experiments, we observed that the TRPV5
channel also had significantly increased sensitivity to the
depletion of PI(4,5)P2 with high concentrations of wortmannin,
suggesting that both TRPV5 and TRPV6 share a similar PI(4,5)
P2-binding site (Fig. 2f). Unlike for TRPV6, current amplitudes
for these mutants were not statistically significantly different from
wild type TRPV5 (Supplementary Figure 9).
Based on the structure of PI(4,5)P2-bound TRPV5 compared
to the lipid-bound TRPV5, the binding of diC8 PI(4,5)P2 to
TRPV5 appears to induce conformational changes related to
channel activity. The pore of the channel widened, which could
allow for the flow of hydrated Ca2+ ions (Fig.3a–d). Specifically,
the Asp542 residues, which line the selectivity filter of the channel
and coordinate Ca2+ ions, point upwards in the extracellular
vestibule of the channel instead of towards the ion conduction
pathway as seen in the lipid-bound structure (Fig. 3d). The
distance between the center of the carboxylate oxygen atoms of
the Asp542 residues in this structure is ~3 Å, which would allow
for partially hydrated Ca2+ ion to flow though the pore of the
channel (Fig. 3c, d). The lower gate of the channel is also wide
open (~12 Å compared to ~8 Å in the lipid-bound state) due to
the movement of the S6 helix and Trp583 upon binding of diC8
PI(4,5)P2 (Fig. 3e), which would facilitate the movement of
partially hydrated Ca2+ ions through the pore (Fig. 3C).
Additionally, diC8 PI(4,5)P2 binding caused global conforma-
tional changes in the S6 and TRP helices, as well as the S4–S5
linker when compared to the lipid-bound structure (Fig. 3f).
Comparison between the diC8 PI(4,5)P2-bound and lipid-
bound TRPV5 structures revealed details of the conformational
changes induced by PI(4,5)P2 binding (Fig. 4). The inositol ring
of the diC8 PI(4,5)P2 head group is positioned close to the lower
gate of the channel, where phosphate groups at position four and
five can interact directly with Arg584 and Arg302, respectively
(Fig. 4a, c). Specifically, the phosphate group at the position four
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Fig. 2 PI(4,5)P2-bound TRPV5 structure and PI(4,5)P2-bound TRPV6 modeling. a The initial reconstruction of PI(4,5)P2-bound TRPV5 in nanodiscs before
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shown in orange. c Zoomed-in view of the TRPV5 PI(4,5)P2 -binding pocket. The PI(4,5)P2-binding site in the TRPV5 channel is located between the
N-linker (R302, R305), S4-S5 linker (K484), and the S6 helix (R584) of the channel. d A model produced by molecular dynamics (MD) simulations of the
predicted interaction between the homologous TRPV6 channel and PI(4,5)P2. e Neutralization of key PI(4,5)P2 interacting residues increases sensitivity to
depletion of PI(4,5)P2 in TRPV6. The TRPV6 currents in oocytes measured before and after incubation with 35 μM wortmannin for 1 h. Current values after
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digit (analysis of variance). f Neutralization of key PI(4,5)P2 interacting residues increases sensitivity to depletion of PI(4,5)P2 in TRPV5. The TRPV5
currents in oocytes measured before and after incubation with 35 μM wortmannin for 1 h. Current values after wortmannin treatment are normalized to
current values before treatment. P-values for significance values are shown after rounding to the first non-zero digit (analysis of variance). The sample size
(n) indicates the number of individual oocytes tested, from at least two different oocyte preparations. Error bars represent ±SEM
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forms a salt bridge with the Arg584 on the S6 helix. This
interaction is facilitated by the rotation of the Arg584 towards PI
(4,5)P2, which pulls the S6 helix away from the center of the pore,
starting at the π-helix (Fig. 3b), and causes an outward shift of the
S4-S5 linker (Fig. 3f). The rotation of Arg584 also induces the
lengthening of the S6 helix and shortens the TRP helix (Fig. 3f,
Fig. 4a, b): in the lipid-bound TRPV5 structure, the transition
between the S6 helix and the TRP helix occurs between Arg584
and Val585, while in the diC8 PI(4,5)P2-bound TRPV5 structure
this transition occurs between residues Gln587 and Glu588. The
extension and rotation of the S6 helix pulls Trp583 out of the
pore and stabilizes its position through an interaction with
Gln587, thus opening the lower gate. The shortening of the TRP
helix causes Glu588 to pull away from Arg302, allowing Arg302
to interact with the phosphate group at position five of the diC8
PI(4,5)P2 head group (Fig. 4c, d). Additionally, Lys484 interacts
with the diC8 PI(4,5)P2 inositol ring, which further electro-
statically stabilizes the position of diC8 PI(4,5)P2 in its binding
pocket (Fig. 4c, d, Supplementary Movie 1).
TRPV5 inhibition by calmodulin. In order to investigate the
mechanism of TRPV5 inactivation by CaM, we incubated
detergent solubilized full-length rabbit TRPV5 with calcium-
activated rat CaM in a 1:20 molar ratio in the presence of 10 mM
CaCl2. The stoichiometry of TRPV5 to CaM has been speculated
to be between one and four molecules of CaM per tetramer3,6,21–23
and the affinity between CaM and the TRPV5 C-terminus esti-
mated at ~0.3 µM24, therefore the high molar ratio was used to
ensure TRPV5 saturation with CaM. This sample yielded a cryo-
EM map at 4.4 Å without applied symmetry (Fig. 5a, Supple-
mentary Figure 10, Supplementary Figure 11, Supplementary
Figure 12, Supplementary Table 1). In this structure, a single CaM
molecule is bound to the intracellular section of TRPV5 at the base
of the pore (Fig. 5a). Both lobes of CaM are resolved and each
bound to different sections of the TRPV5 C-terminus (Fig. 5a, b,
Supplementary Figure 12). Despite the interaction with CaM, the
CaM-bound conformation of TRPV5 is almost identical to the
lipid-bound conformation of TRPV5, with an RMSD of ~0.6 A
overall and a very similar pore profile (Fig. 5c, d). Additionally,
annular lipids were also identified in the CaM-bound
TRPV5 structure in similar positions to those in the lipid-bound
TRPV5 structure in detergent (Figs. 1b and 5a).
CaM is bound with the C-lobe at the base of the pore and the
N-lobe resting against the ankyrin repeats of two adjacent
TRPV5 monomers (Fig. 5a, b). A portion of the CaM N-lobe
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(Gly41-Ile64) and the linker between the CaM two lobes
(Lys78-Ser82) are visible only as broken density and were
excluded from the model (Fig. 6a). A peptide from the
C-terminus of TRPV5 (His699-Thr709) is bound to the CaM
C-lobe, with TRPV5 Trp702 making critical contacts with the
CaM-binding pocket, as previously reported23 (Fig. 6a, c). This
peptide was arbitrarily assigned to TRPV5 chain A in the model,
but no connections could be seen between the density for this
peptide and any TRPV5 monomer. An extension of the TRPV5
chain A C-terminus (Asn640-Lys652) forms a helix and is bound
to the hydrophobic binding pocket of the CaM N-lobe (Fig. 6b).
This interaction is mediated by numerous hydrophobic contacts:
Val644, Leu645, Val648, and Phe651 on the TRPV5 side and
Phe20, Leu33, Val36, and Leu64 on the CaM side (Fig. 6a, d). A
loop of the CaM C-lobe (Gly114-Thr118) crosses over the bottom
of the TRPV5 pore, placing Lys116 directly into the pore. The
ε-amino group of Lys116 sits in between the four Trp583 residues
of the lower gate, forming a cation–π interaction and thereby
blocking the flow of ions through the pore (Fig. 6e). To test the
functional importance of Trp583 in TRPV5 inhibition by CaM,
we performed excised inside out patch clamp experiments. Wild
type TRPV5 currents were robustly inhibited by Ca2+-CaM
(0.2 μM CaM, 3 μM free Ca2+) applied to the inner leaflet of the
patch membrane (Fig. 6f, h), as reported previously for TRPV613.
On the other hand, the Trp583 to Leu mutant of TRPV5 was
essentially not inhibited by Ca2+-CaM (Fig. 6g, h). Thus, this
cation–π interaction appears to be critical for CaM-induced
inhibition of TRPV5 (Fig. 6f–h).
Discussion
Here we have presented three structures of TRPV5, one in the
presence of endogenous lipids that are likely to be involved in
maintaining the structure of TRPV5, one bound to its endogen-
ous activator, PI(4,5)P2, and one bound to its endogenous inhi-
bitor, CaM. The high-resolution, lipid-bound TRPV5 has allowed
for more accurate model building of TRPV5 than available pre-
viously4. This structure also identified the binding pockets for
several high affinity lipids which were consistently seen in all
TRPV5 structures presented here. These binding pockets have the
potential to be druggable areas of the TRPV5 channel as they are
both membrane and solvent accessible and are in contact with
regions that have been reported to be able to transmit con-
formational rearrangements to the pore in other TRPV family
channels4,15,25.
PI(4,5)P2 is a conserved positive regulator of most TRP
channels20. The TRPV5-bound PI(4,5)P2 structure revealed
directly how a TRP channel is opened by this important endo-
genous lipid at the molecular level. Similar binding sites for PI
(4,5)P2 have been theoretically predicted for TRPV126 and
TRPV614 channels using computational modeling and experi-
mental approaches, suggesting that the S4–S5 linker plays an
essential role in this interaction. Our cryo-EM structure directly
demonstrates an interaction between PI(4,5)P2 and TRPV5
through the N-linker, the S4–S5 linker and the S6 helix of each
TRPV monomer (Fig. 2). Comparison between the PI(4,5)P2-
bound and lipid-bound TRPV5 structures reveals that binding of
PI(4,5)P2 near to the lower gate of the TRPV5 channel induces
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conformational changes in the pore, which allows for the flow of
Ca2+ ions (Figs. 3 and 7).
The CaM-bound structure has provided the first structural
insight into how TRPV5 ion flow is inhibited by CaM. It is clear
that the binding of a single CaM molecule completely obstructs
the intracellular side of the pore, effectively blocking ion per-
meation (Fig. 7). This study also showed that while CaM binds to
the predicted areas in the C-terminus of TRPV5, it also directly
interacts at an additional C-terminal-binding site (Fig. 6). Taken
together, the lipid-bound and CaM-bound TRPV5 structures
provide additional evidence for the static nature of some TRPV
subfamily channels15,25. The minimal movement (RMSD ~0.6 Å)
between the two structures implies that large conformational
changes in the upper and lower gates of TRPV5 may not be
necessary for effective endogenous inhibition.
It has previously been shown that the N-lobe and C-lobe of
CaM have different affinities for calcium ions, with the C-lobe
having a six-fold higher affinity for calcium ions than the
N-lobe27. Other groups have proposed that this allows the CaM
C-lobe to be constantly bound to the distal C-terminus of TRPV5
at normal cellular calcium levels, keeping a constant supply of
CaM near the pore23,28. In this model, the N-lobe only binds to
the C-terminus of TRPV5 when calcium is high and the pore
needs to be closed, and the second CaM binding event may
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Fig. 5 CaM-bound structure of TRPV5. a Side and bottom view of the CaM-bound TRPV5 density map at 4.4 Å resolution. Density for TRPV5 is shown in
gray, annular lipids shown in khaki, and CaM shown in hot pink. b Cartoon representation of the CaM-bound TRPV5 model in a side and bottom view.
TRPV5 is shown in blue and CaM is shown in hot pink. c Pore diagram of CaM-bound TRPV5. Constriction residues are labeled and shown as sticks. d Plot
of pore radii of CaM-bound TRPV5 as a function of distance through the pore is shown in blue. For reference, the lipid-bound TRPV5 pore graph is shown in
pink. The dotted line indicates the radius of a calcium ion
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stabilize the position of CaM at the base of the pore and lead to
the occlusion of the channel23,28. The CaM N-lobe-binding site at
TRPV5 residues Asn640-Lys652 could compliment the previous
model, by potentially “reeling in” CaM when calcium levels are
high and bringing the CaM C-lobe into close proximity with
the base of the pore.
Overall, our structural studies have provided molecular insights
into the endogenous modulation of TRPV5 that could guide
therapeutics design for a variety of calcium dependent kidney
diseases.
Methods
Protein expression and purification. Full-length rabbit TRPV5 was expressed
with a 1D4 affinity tag in Saccharomyces cerevisiae29,30. The membranes were lysed
and harvested using a M-110Y microfluidizer and ultracentrifugation. Lysed
membranes containing TRPV5 were solubilized in Buffer A (150 mM NaCl, 2 mM
TCEP, 1 mM PMSF, 20 mM HEPES pH 8, 10% glycerol, and 0.87 mM LMNG).
Non-soluble material was removed via ultracentrifugation. Detergent solubilized
TRPV5 was then purified using CnBr-activated Sepharose 4B beads conjugated to
1D4 specific antibodies. The beads were washed with Buffer B (150 mM NaCl,
2 mM TCEP, 20 mM HEPES pH 8, and 0.064 mM DMNG) and TRPV5 was eluted
using Buffer B with the addition of 3 mg/mL 1D4 peptide.
The sample involved in the reconstruction of lipid-bound TRPV5 in detergent
was then subjected to size-exclusion chromatography (Superose 6, GE Healthcare)
in Buffer B. This sample was concentrated to ~2.5 mg/mL and incubated with
soluble diC8 PI(4,5)P2 (dioctanoyl phosphatidylinositol 4,5-bisphosphate) at a final
concentration of 200 µM for 30 min prior to vitrification.
For the sample that was reconstituted into nanodiscs, after elution from the
Sepharose beads TRPV5 was incubated with MSP2N2 and soy polar lipid extract
(Avanti Polar Lipids, Inc.) in a molar ratio of 1:1:200 (TRPV5:MSP2N2:Soy Polar
Lipids) for 30 min. To produce purified MSP2N2 for the reconstitution, MSP2N2
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(Addgene) was transformed into BL21 (DE3) cells, then grown on LB plates
containing 30 µg/mL kanamycin. Cells expressing MSP2N2 were then grown in TB
supplemented with 0.2% glucose and 30 µg/mL kanamycin at 37 °C with shaking.
When the culture reached an OD600 of ~0.5 the temperature was reduced to 28 °C.
The culture was induced with 1 mM IPTG at an OD600 of ~1.0. After 3 h the
culture was harvested by centrifugation and the cell pellet was resuspended in a
buffer containing 100 mM NaCl, 20 mM Tris–HCl, pH 7.4, 1 mM PMSF and a
complete EDTA-free protease inhibitor cocktail tablet (Roche). Cells were lysed via
homogenization and centrifuged at 30,000×g for 30 min. The lysate supernatant
was bound to Ni-NTA equilibrated with Buffer C (100 mM NaCl, 20 mM
Tris–HCl, pH 7.4). The bound resin was washed with four bed volumes of Buffer C
containing 1% Triton X-100 followed by four bed volumes of Buffer C
supplemented with 50 mM sodium cholate and four bed volumes of Buffer C
containing 20 mM imidazole. The MSP2N2 was eluted from the Ni-NTA resin
with Buffer C supplemented with 300 mM imidazole. The elution was passed
through a desalting column equilibrated with 50 mM Tris–HCl, pH 7.5, 100 mM
NaCl, and 0.5 mM EDTA. Desalted MSP2N2 was utilized for reconstitution31. Soy
polar lipids were dried under nitrogen flow for 3 h prior to reconstitution and dried
lipids were resuspended with a 1:200 molar ratio of lipids to DMNG before being
added to the protein mixture. Bio-Beads (Bio-Rad, Bio-Beads SM-2 Absorbent
Media) were added to the TRPV5, MSP, lipid mixture for 1 h. Fresh Bio-Beads
were then added and allowed to incubate overnight. The reconstituted nanodiscs
were further purified using size-exclusion chromatography (Superose 6, GE
Healthcare) in buffer containing 150 mM NaCl, 2 mM TCEP, and 20 mM HEPES
pH 8. This sample was concentrated to ~2.8 mg/mL and incubated with soluble
diC8 PI(4,5)P2 at a final concentration of 400 µM for 30 min prior to vitrification.
Rat CaM in the pET 28b vector was expressed in Rosetta 2(DE3) Escherichia
coli. Cells were grown in Terrefic Brothe supplemented with 30 µg/mL kanamycin
and 35 µg/mL chlorempinacole at 37 °C. The cells were resuspended in buffer
containing 20 mM Tris, 150 mM NaCl, 1 mM EDTA, pH 7.5, 1 mM PMSF, and a
complete EDTA-free protease inhibitor cocktail tablet (Roche) then sonicated for
1 h. The lysate was passed through low substitution phenyl sepharose fast flow
column (GE Healthcare) equilibrated with 20 mM Tris, 1 mM EGTA, pH 7.5
buffer. The flow through was then supplemented with 20 mM CaCl2 and run
through a low substitution phenyl sepharose fast flow column equilibrated with
20 mM Tris, 500 mM NaCl, 1 mM CaCl2, pH 7.5. The column was washed with
20 mM Tris, 1 mM CaCl2, pH 7.5, and the CaM was eluted with 20 mM Tris, 1 mM
EGTA, pH 7.5. CaM was further purified using an AKTA purifier (GE Healthcare)
with the following buffer: 10 mM Tris, 50 mM NaCl, 10 mM CaCl2, pH 7.532.
Purified TRPV5 was incubated for 1 h with 10 mM CaCl2 and the purified rat CaM
at a molar ratio of 1:20 (TRPV5 tetramer:CaM) after elution from the Sepharose
beads. The TRPV5–CaM mixture was then further purified using size-exclusion
chromatography (Superose 6, GE Healthcare) in Buffer B. No chelating agents were
added to Buffer B; thus, trace amounts of calcium are present in the final sample.
The peak containing CaM-bound TRPV5 was concentrated to ~3 mg/mL.
Cryo-EM data acquisition. For all samples, fluorinated Fos-Choline-8 was added
to the concentrated protein to a final concentration of 3 mM immediately prior to
vitrification. Samples were double blotted on 200 mesh Quantifoil 1.2/1.3 grids
(Quantifoil Micro Tools) with 3.5 µL per blot and plunge frozen in liquid ethane
using a Vitrobot (Thermo Fisher Scientific). Grids containing TRPV5 and diC8 PI
(4,5)P2 in detergent, as well as grids with CaM-bound TRPV5 were imaged with a
300 kV Titan Krios microscope equipped with a Gatan K2 Summit direct detector
camera. Super resolution movies (50 frames) were captured for 10 s each with one
frame collected every 0.2 s. The resultant pixel size and dose rate were 0.55 Å/pix
and ~8 electrons/pix/s, respectively. Images were collected in a defocus range
between 1.0 and 2.5 µm under focus in an automated fashion using Leginon
software33.
Grids containing TRPV5 and diC8 PI(4,5)P2 in nanodiscs were also imaged
with a 300 kV Titan Krios microscope equipped with a Gatan K2 Summit direct
detector camera. Super resolution movies (40 frames) were captured with an 8 s
exposure time in super resolution mode resulting in a pixel size and dose rate of
0.532 Å/pix and ~6 electrons/pix/sec, respectively. Images were collected in a
defocus range between 1.25 and 2.5 µm under focus.
Image processing. For the dataset of lipid-bound TRPV5 in detergent, Motion-
Cor234 was used to correct for beam induced motion and to bin the images to a
final pixel size of 1.1 Å, producing both summed and dose weighted micrographs.
CTF estimation of the summed micrographs was preformed using Gctf35. All other
image processing was performed using RELION on the dose weighted micrographs
unless otherwise mentioned18,19. Approximately 2500 particles were picked
manually from 3889 micrographs and sorted into 2D classes. The best classes were
used as templates for autopicking. After autopicking, 2D classification was used to
remove false positives and suboptimal particles. The remaining ~241,000 particles
were reconstructed into a single electron density map with C4 symmetry using the
3D auto-refine option in RELION followed by 3D classification into eight classes
without assigning angles to the particles. The initial model used for 3D refinement
and classification was produced by applying a low-pass filter of 60 Å to the pre-
viously published TRPV5 cryo-EM structure4. The best class by manual inspection
underwent multiple rounds of 3D refinement followed by 3D classification until the
best ~26,000 particles were able to be reconstructed into a 4.4 Å map. The mask
used for this reconstruction was created from the original 3D auto-refinement of
~241,000 particles adjusted to a threshold of 0.005, low-pass filtered to 15 Å and a
soft edge of five pixels was applied. A separate dataset collected under the same
conditions from grids prepared at the same time as the sample above produced
3062 additional micrographs. The same methods as above were implemented and
resulted in a map containing ~19,000 particles that was reconstructed to 4.2 Å.
These particles were then combined using the JoinStar command in Relion to
produce a particle set of ~45,000 particles that were refined to 4.1 Å in RELION
(Supplementary Figure 2). A B-factor of −174 was then applied to the unsharpened
map using Bfactor software and the final resolution of 3.9 Å was determined using
rmeasure software36,37. Local resolutions were estimated using the RESMAP
software38.
For the dataset of PI(4,5)P2-bound TRPV5 in nanodiscs, MotionCor234 was
used to correct for beam-induced motion and to bin the images to a final pixel size
of 1.1 Å, producing both summed and dose-weighted micrographs. CTF estimation
of the summed micrographs was preformed using Gctf35. All other image
processing was performed using RELION on the dose-weighted micrographs
unless otherwise mentioned18,19. To create templates for autopicking, 2112
particles were manually picked from 1575 micrographs and sorted into 21 classes.
The best classes were used to autopick 493,047 particles which were then subjected
to 2D classification into 200 classes to remove false positives and suboptimal
particles. The best classes contained 121,980 particles, which were refined to 4.4 Å
using 3D AutoRefine with C4 symmetry in the absence of a mask using the same
initial model as in the lipid-bound structure. A mask was created of this structure
by adjusting the threshold to 0.005, lowpass filtering to 15 Å and applying a soft
edge of five pixels. The 4.4 Å structure was postprocessed using the above mask to
produce the Initial 3D Reconstruction at 4.3 Å (Supplementary Figure 4). A
cylinder with a radius of 40 Å and height of 15 Å was created in Chimera, centered
on the pore at the height of the TRP helices. This cylinder was used to make a mask
at a threshold of 0.5, an extended edge of two pixels, and a soft edge of five pixels.
This mask was then used for particle subtraction, where everything outside of this
mask was subtracted, as previously described39. The subtracted particles were then
sorted by 3D classification into five classes without assigning angles, yielding three
high-resolution classes. Two of these classes had density for PI(4,5)P2 (total of
~72,000 particles) and one had no PI(4,5)P2 density (~30,000 particles). We
swapped both sets of subtracted particles back to the unsubtracted particles and
refined both sets using the mask previously used to refine the ~121,000 particle
map. The ~30,000 particles for the class without PI(4,5)P2 were refined to 4.5 Å in
RELION. Postprocessing was run on this data in RELION using the same mask as
previously with an applied b factor of −200, leading to a final resolution of 4.4 Å.
The ~72,000 particles were then sorted again by 3D classification into three classes
without assigning angles. The best of these classes consisted of ~25,500 particles
and was refined to 4.1 Å in RELION. Postprocessing was run on this data in
RELION using the same mask as previously with an applied b factor of −150,
leading to a final resolution of 4.0 Å (Supplementary Figure 4). Local resolutions
were estimated using RESMAP38.
For the dataset of CaM-bound TRPV5 in detergent, MotionCorr234 was used
without gain correction and without binning to produce both summed and dose
weighted micrographs with a final pixel size of 1.1 Å. CTF estimation of the
summed micrographs was preformed using Gctf35. All other image processing was
performed using RELION on the dose weighted micrographs unless otherwise
mentioned18,19. To create templates for autopicking, 3,125 particles were manually
picked from 2118 micrographs and sorted into 30 classes. The best classes were
used to autopick 391,648 particles which were then subjected to 2D classification
into 100 classes to remove false positives and suboptimal particles. The best classes
contained 153,776 particles, which were refined to 5.4 Å using 3D AutoRefine with
C1 symmetry in the absence of a mask using the same initial model as in the lipid-
bound structure. At this point, there was clearly density present in the region
between the ARDs of the TRPV5 monomers, but it appeared to be asymmetrical.
To make sure that information for all the asymmetrical features was aligned in the
same orientation, we decided to use symmetry expansion. The ~154,000 particles
from the initial C1 reconstruction were refined in C4 to generate symmetry
operators. RELION symmetry expansion in C4 was used to expand the particle
stack and ensure that all the information for CaM was present in all four possible
orientations. A sphere of radius 25 Å was created in Chimera and placed at the base
of the pore so that the entire region with density for CaM was in the sphere. A
mask was made of this sphere in RELION, at a threshold of 0.1, extended by five
pixels, and with a soft edge of five pixels. This spherical mask was used for particle
subtraction, as described above, and then the subtracted particles were sorted into
five classes with 3D classification. The resulting classes captured CaM in the four
possible orientations, with approximately equal numbers of particles, as well as a
class without CaM bound. The class with the best resolution was chosen, consisting
of ~129,000 particles, and we reverted to the unsubtracted particles and refined
these particles. There was still some heterogeneity in the CaM, so we further
classified the particles into three classes, resulting in a class with ~47,500 particles
that refined to 4.7 Å in RELION. After postprocessing in RELION with an applied
b factor of −200, this data reached a resolution of 4.4 Å (Supplementary Figure 11).
Local resolutions were estimated using RESMAP38.
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Model building. The previously published model of TRPV5 bound to econazole
(PDB 6B5V)4 was used as an initial model and docked to the cryo-EM map of
lipid-bound TRPV5. The model was manually adjusted in Coot40 and refined with
imposed four-fold NCS using phenix.real_space_refinement41. The lipid-bound
TRPV5 model was docked into the PI(4,5)P2-bound TRPV5 map and manually
adjusted and refined as before. The lipid-bound TRPV5 model was docked into the
CaM-bound TRPV5 map. To model CaM into the extra density, the N-lobe
(residues 6–77) and C-lobe (residues 83–147) of a calcium-bound CaM structure
(PDB 1CLL) were separated and independently fit in Chimera to the two lobes of
density visible at the base of the pore. A portion of the N-lobe was visible only as
broken density, and so was removed from the model. The TRPV5 C-terminal
peptide from state 01 of PDB 5OEO was fit into the remaining density near the
C-lobe in Chimera. An extension of the C-terminus of TRPV5 chain A was
modeled into helical density in the peptide-binding pocket of the CaM N-Lobe.
This assembly was manually adjusted in Coot and refined without NCS using
phenix.real_space_refinement.
The final models were randomized in PHENIX41 by 0.5 Å and refined against
one of the half maps. EMAN2 was used to generate FSC curves between this refined
test model and each half map, as well as between the final model and the summed
map for each model. The pore radii were generated using HOLE42. Figures were
made in Pymol43 and Chimera44.
Xenopus oocyte electrophysiology. Oocyte sacs were extracted from female
Xenopus laevis frogs (Xenopus Express) and digested with 0.2 mg/ml collagenase
(Sigma) in OR2 solution (82.5 mM NaCl, 2 mM KCl, 1 mM MgCl2, and 5 mM
HEPES, pH 7.4) overnight at 18 °C. Oocytes were maintained in OR2 solution plus
1.8 mM CaCl2 and 1% penicillin/streptomycin (Mediatech) at 18 °C. cRNA was
generated using the mMessage mMachine kit (Thermo Fisher); point mutations
were introduced using the Quikchange mutagenesis kit (Agilent Genomics). cRNA
(20 ng) was injected using a nanoliter injector system (World Precision Instru-
ments). The W583L mutant of TRPV5 was kept in OR2 with 0.1 mM CaCl2, to
avoid Ca2+ overload and cell damage. The experiments were performed 48–72 h
after injection. Purified CaM from bovine testes was purchased from Sigma.
Two-electrode voltage clamp (TEVC) measurements were performed as
described earlier14; briefly oocytes were initially placed in a solution containing
97 mM NaCl, 2 mM KCl, 1 mM MgCl2, and 5 mM HEPES, pH 7.4, where TRPV5
or TRPV6 currents are largely blocked by Mg2+ and trace amounts of Ca2+ in the
medium. Monovalent currents were initiated with changing the solution containing
96 mM LiCl, 1 mM EGTA, and 5 mM HEPES, pH 7.4. Currents were recorded with
thin-wall inner filament-containing glass pipettes (World Precision Instruments)
filled with 3M KCl in 1% agarose. Currents were recorded with a GeneClamp 500B
amplifier (Molecular Devices using a ramp protocol from –100 to +100 mV
(0.25 mV/ms), immediately preceded by a 100-ms step to −100 mV, applied once
every second; holding potential was 0 mV.
Excised inside-out patch clamp experiments were performed as described earlier13
using borosilicate glass pipettes (World Precision Instruments) of 0.8–1.7MΩ
resistance. The electrode pipette solution contained 96mM LiCl, 1 mM EGTA, and
5mM HEPES, pH 7.4. After establishing giagohm resistance seals on devitellinized
Xenopus oocytes, the currents were measured using an Axopath 200B amplifier
(Molecular Devices). We used a ramp protocol from −100 to 100mV, performed
once a second, immediately preceded by a 100-ms step to −100mV. The perfusion
solution contained 93mM potassium gluconate, 5 mM HEDTA, 5mM HEPES, with
the pH adjusted to 7.4. To obtain 3 μM free Ca2+, 2.5mM Ca2+ gluconate was added.
The bath was connected with the ground electrode through an agar bridge. Animal
procedures were approved by the Institutional Animal Care and Use Committee of
Rutgers New Jersey Medical School, and all animal procedures were performed in
accordance with the approved ethical guidelines.
TRPV6 computational modeling. We generated an almost full-length atomistic
model of TRPV6 by performing comparative homology modeling using the
structure of the closed state of TRPV1 as a template (PDB:3J5P). We extracted the
pairwise sequence alignment between TRPV1 and TRPV6 from the multiple
sequence alignment containing about 3000 sequences45. We then generated 288
models using ROSETTA46 and discarded the 50 ones with the lowest score. We
performed clustering on the remaining 248 structures and found two major clusters
differing by the conformation of the S2–S3 segment. Due to the absence of sig-
nificant structural constraints from the template, we modeled this region of TRPV6
ab initio.
To investigate the binding mode of PI(4,5)P2 we considered a model ligand and
performed a series of stochastic optimizations of its positions with respect to the
TRPV6 structure using the program AUTODOCK47. The model ligand is a
simplified version PI(4,5)P2 that contains the entire head group, the glycerol
moiety and part of the acyl chains (up to the third carbon atom). This choice
allowed us to explore thoroughly the conformational space by ignoring the large
number of degrees of freedom describing the configuration of the flexible acyl
chain. Since not all the binding poses of the model ligand correspond to a
geometrically viable conformation of PI(4,5)P2, we post-processed the output of
docking and selected only those binding poses in which the acyl chain is correctly
positioned with respect to the lipid bilayer. The conformational search was
restricted to a specific region of the channel encompassing the S4–S5 linker, the
N-term sections of S1, S3, and S5, the C-term section and S2 and S4, the S2–S3
loop, the N-term section of the TRP box and the adjacent part of the cytoplasmic
domain. The region was large enough to contain at least two adjacent subunits to
allow for the identification of potential interactions at their interface. For each
structure of TRPV6 (20 in total) 1000 docking experiments were performed using
the Lamarckian genetic algorithm allowing for a maximum of 250,000 energy
evaluations.
We performed molecular dynamics simulations of the PI(4,5)P2-TRPV6 and PI
(4,5)P2-TRPV1 complexes and of the TRPV6 apo channel (with no bound PI(4,5)
P2). We used the naturally occurring long acyl chain version (arachydonyl-stearyl,
AASt) PI(4,5)P2 for these simulation. As initial configurations, we considered the
structural models with the highest scores. The channels were embedded into a fully
hydrated 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine membrane
surrounded by a 150 mM KCl solution. Overall, the system contains more than
300,000 atoms. During the initial equilibration protocol, we gradually released each
component of the (water and ions, lipid tails, lipid head groups, protein side chains
and protein backbone) system from positional restraints. During the production
run, trajectories were collected for 0.7 μs. Simulations were performed at constant
temperature and pressure (1 atm, 300 K) using the Langevin piston approach using
NAMD 2.1048. The CHARMM36 force field49 was used to describe the protein, the
ions and the lipid molecules. For the vdW interactions, we used a cutoff of 11 Å
with a switching function between 8 and 11 Å. The long-range component of
electrostatic interactions was calculated using the particle mesh Ewald approach50
using a cutoff for the short-range component of 11 Å. The equations of motion
were integrated using the RESPA multiple time-step algorithm51, with a time step
of 2 fs, and long-range interactions calculated every other step.
Data availability
The cryo-EM density maps and atomic coordinates of all structures presented in the text
are deposited into the Electron Microscopy Data Bank and Protein Data Bank under the
following access codes: Lipid-Bound TRPV5 in detergent (EMB-7965, PDB 6DMR); PI
(4,5)P2-Bound TRPV5 in nanodiscs (EMB-7966, PDB 6DMU); CaM-Bound TRPV5 in
detergent (EMB-7967, PDB 6DMW). All data is available from the corresponding author
upon reasonable request.
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